Published in J Allergy Clin Immunol on October 01, 2004
Targeting IL-17 and TH17 cells in chronic inflammation. Nat Rev Drug Discov (2012) 4.70
Th17 cells in human disease. Immunol Rev (2008) 4.27
Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy. Cytokine (2008) 2.19
The roles of CCR6 in migration of Th17 cells and regulation of effector T-cell balance in the gut. Mucosal Immunol (2009) 1.78
IL-17 regulates CXCL1 mRNA stability via an AUUUA/tristetraprolin-independent sequence. J Immunol (2009) 1.24
Regulation of FoxP3 regulatory T cells and Th17 cells by retinoids. Clin Dev Immunol (2008) 0.98
Spinal interleukin-17 promotes thermal hyperalgesia and NMDA NR1 phosphorylation in an inflammatory pain rat model. Pain (2012) 0.90
Transcriptional regulation of cytokine function in airway smooth muscle cells. Pulm Pharmacol Ther (2009) 0.90
Induced elastin regeneration by chronically activated smooth muscle cells for targeted aneurysm repair. Acta Biomater (2009) 0.88
Role of TH-17 cells in rheumatic and other autoimmune diseases. Rheumatology (Sunnyvale) (2011) 0.86
Does airway smooth muscle express an inflammatory phenotype in asthma? Br J Pharmacol (2011) 0.86
The other T helper cells in asthma pathogenesis. J Allergy (Cairo) (2010) 0.84
Corticosteroids and β₂-agonists upregulate mitogen-activated protein kinase phosphatase 1: in vitro mechanisms. Br J Pharmacol (2012) 0.82
Cyclin D1 in ASM Cells from Asthmatics Is Insensitive to Corticosteroid Inhibition. J Allergy (Cairo) (2012) 0.77
IL-17A enhances IL-13 activity by enhancing IL-13-induced signal transducer and activator of transcription 6 activation. J Allergy Clin Immunol (2016) 0.75
Dysfunctional interaction of C/EBPalpha and the glucocorticoid receptor in asthmatic bronchial smooth-muscle cells. N Engl J Med (2004) 3.13
Interaction between glucocorticoids and beta2 agonists on bronchial airway smooth muscle cells through synchronised cellular signalling. Lancet (2002) 1.98
The CXCL10/CXCR3 axis mediates human lung mast cell migration to asthmatic airway smooth muscle. Am J Respir Crit Care Med (2005) 1.95
Counseling about turbuhaler technique: needs assessment and effective strategies for community pharmacists. Respir Care (2005) 1.94
User error with Diskus and Turbuhaler by asthma patients and pharmacists in Jordan and Australia. Respir Care (2011) 1.67
PI3K is required for proliferation and migration of human pulmonary vascular smooth muscle cells. Am J Physiol Lung Cell Mol Physiol (2002) 1.57
The insomnia patient perspective, a narrative review. Behav Sleep Med (2013) 1.48
Primary health care teams and the patient perspective: a social network analysis. Res Social Adm Pharm (2013) 1.45
Improved asthma outcomes with a simple inhaler technique intervention by community pharmacists. J Allergy Clin Immunol (2007) 1.41
Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br J Clin Pharmacol (2004) 1.40
Targeting p38 MAPK pathway for the treatment of Alzheimer's disease. Neuropharmacology (2009) 1.38
Evaluation of a novel educational strategy, including inhaler-based reminder labels, to improve asthma inhaler technique. Patient Educ Couns (2008) 1.37
Complementary and alternative medicine use in asthma: who is using what? Respirology (2006) 1.30
Extracellular matrix proteins modulate asthmatic airway smooth muscle cell proliferation via an autocrine mechanism. J Allergy Clin Immunol (2004) 1.27
Corticosteroids reduce IL-6 in ASM cells via up-regulation of MKP-1. Am J Respir Cell Mol Biol (2008) 1.27
Effective anti-platelet and COX-1 enzyme inhibitors from pungent constituents of ginger. Thromb Res (2003) 1.25
IL-17A acts via p38 MAPK to increase stability of TNF-alpha-induced IL-8 mRNA in human ASM. Am J Physiol Lung Cell Mol Physiol (2006) 1.20
Dual ERK and phosphatidylinositol 3-kinase pathways control airway smooth muscle proliferation: differences in asthma. J Cell Physiol (2008) 1.18
S100A12 provokes mast cell activation: a potential amplification pathway in asthma and innate immunity. J Allergy Clin Immunol (2006) 1.14
Impact on medication use and adherence of Australian pharmacists' diabetes care services. J Am Pharm Assoc (2003) (2005) 1.13
Connective tissue growth factor induces extracellular matrix in asthmatic airway smooth muscle. Am J Respir Crit Care Med (2005) 1.12
Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br J Clin Pharmacol (2005) 1.11
β2-Agonist induced cAMP is decreased in asthmatic airway smooth muscle due to increased PDE4D. PLoS One (2011) 1.10
CD40 and OX40 ligand are increased on stimulated asthmatic airway smooth muscle. J Allergy Clin Immunol (2005) 1.08
RAGE and TLRs: relatives, friends or neighbours? Mol Immunol (2013) 1.05
Long-term maintenance of pharmacists' inhaler technique demonstration skills. Am J Pharm Educ (2009) 1.04
RAGE: a new frontier in chronic airways disease. Br J Pharmacol (2012) 1.04
PAR-2 activation, PGE2, and COX-2 in human asthmatic and nonasthmatic airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol (2003) 1.03
Src is necessary and sufficient for human airway smooth muscle cell proliferation and migration. FASEB J (2004) 1.01
Effect of IL-6 trans-signaling on the pro-remodeling phenotype of airway smooth muscle. Am J Physiol Lung Cell Mol Physiol (2006) 0.99
Expression of connective tissue growth factor in asthmatic airway smooth muscle cells. Am J Respir Crit Care Med (2003) 0.99
A phosphodiesterase 4 inhibitor inhibits matrix protein deposition in airways in vitro. J Allergy Clin Immunol (2006) 0.96
Programmable, pattern-memorizing polymer surface. Adv Mater (2011) 0.94
Interactive small-group asthma education in the community pharmacy setting: a pilot study. J Asthma (2007) 0.93
Gypenosides derived from Gynostemma pentaphyllum suppress NO synthesis in murine macrophages by inhibiting iNOS enzymatic activity and attenuating NF-kappaB-mediated iNOS protein expression. Nitric Oxide (2003) 0.93
Multidisciplinary collaboration in primary care: through the eyes of patients. Aust J Prim Health (2013) 0.93
Mast cells produce novel shorter forms of perlecan that contain functional endorepellin: a role in angiogenesis and wound healing. J Biol Chem (2012) 0.92
MKP-1: a negative feedback effector that represses MAPK-mediated pro-inflammatory signaling pathways and cytokine secretion in human airway smooth muscle cells. Cell Signal (2011) 0.92
Asthmatic airway smooth muscle CXCL10 production: mitogen-activated protein kinase JNK involvement. Am J Physiol Lung Cell Mol Physiol (2012) 0.91
'Proliferative' and 'synthetic' airway smooth muscle cells are overlapping populations. Immunol Cell Biol (2004) 0.89
Sphingosine 1-phosphate induces MKP-1 expression via p38 MAPK- and CREB-mediated pathways in airway smooth muscle cells. Biochim Biophys Acta (2012) 0.88
Novel p38 MAPK inhibitor ML3403 has potent anti-inflammatory activity in airway smooth muscle. Eur J Pharmacol (2010) 0.87
Pro-inflammatory and immunomodulatory functions of airway smooth muscle: emerging concepts. Pulm Pharmacol Ther (2012) 0.87
Phosphatidylinositol 3-kinase isoform-specific effects in airway mesenchymal cell function. J Pharmacol Exp Ther (2011) 0.85
Connective tissue growth factor and vascular endothelial growth factor from airway smooth muscle interact with the extracellular matrix. Am J Physiol Lung Cell Mol Physiol (2005) 0.85
Long-acting β2-agonists increase fluticasone propionate-induced mitogen-activated protein kinase phosphatase 1 (MKP-1) in airway smooth muscle cells. PLoS One (2013) 0.85
Increased sensitivity of asthmatic airway smooth muscle cells to prostaglandin E2 might be mediated by increased numbers of E-prostanoid receptors. J Allergy Clin Immunol (2004) 0.84
Inhibitors of Phosphodiesterase 4, but Not Phosphodiesterase 3, Increase β2-Agonist-Induced Expression of Antiinflammatory Mitogen-Activated Protein Kinase Phosphatase 1 in Airway Smooth Muscle Cells. Am J Respir Cell Mol Biol (2015) 0.84
Gingerol metabolite and a synthetic analogue Capsarol inhibit macrophage NF-kappaB-mediated iNOS gene expression and enzyme activity. Planta Med (2006) 0.84
Proteasomal inhibition upregulates the endogenous MAPK deactivator MKP-1 in human airway smooth muscle: mechanism of action and effect on cytokine secretion. Biochim Biophys Acta (2010) 0.83
Corticosteroids inhibit sphingosine 1-phosphate-induced interleukin-6 secretion from human airway smooth muscle via mitogen-activated protein kinase phosphatase 1-mediated repression of mitogen and stress-activated protein kinase 1. Am J Respir Cell Mol Biol (2014) 0.83
TLR2 ligand engagement upregulates airway smooth muscle TNFα-induced cytokine production. Am J Physiol Lung Cell Mol Physiol (2012) 0.82
Differential regulation of extracellular matrix and soluble fibulin-1 levels by TGF-β₁ in airway smooth muscle cells. PLoS One (2013) 0.82
Insomnia patients' help-seeking experiences. Behav Sleep Med (2013) 0.82
Cell density and serum exposure modify the function of the glucocorticoid receptor C/EBP complex. Am J Respir Cell Mol Biol (2007) 0.82
Airway basement membrane perimeter in human airways is not a constant; potential implications for airway remodeling in asthma. J Appl Physiol (1985) (2004) 0.82
Rhinovirus-induced exacerbations of asthma: How is the {beta}2-adrenoceptor implicated? Am J Respir Cell Mol Biol (2009) 0.81
Experiences of community pharmacists involved in the delivery of a specialist asthma service in Australia. BMC Health Serv Res (2012) 0.81
Performance of a brief asthma control screening tool in community pharmacy: a cross-sectional and prospective longitudinal analysis. Prim Care Respir J (2014) 0.80
Preparation and evaluation of controlled release microparticles for respiratory protein therapy. J Pharm Sci (2009) 0.80
Estradiol stabilizes the 105-kDa phospho-form of the adhesion docking protein NEDD9 and suppresses NEDD9-dependent cell spreading in breast cancer cells. Biochim Biophys Acta (2010) 0.80
The effect of asthma therapeutics on signalling and transcriptional regulation of airway smooth muscle function. Pulm Pharmacol Ther (2008) 0.80
β2-Agonists upregulate PDE4 mRNA but not protein or activity in human airway smooth muscle cells from asthmatic and nonasthmatic volunteers. Am J Physiol Lung Cell Mol Physiol (2011) 0.80
A pharmacy asthma service achieves a change in patient responses from increased awareness to taking responsibility for their asthma. Int J Pharm Pract (2014) 0.80
Dimethylfumarate inhibits CXCL10 via haem oxygenase-1 in airway smooth muscle. Eur Respir J (2012) 0.78
G-protein-coupled receptor agonists differentially regulate basal or tumor necrosis factor-alpha-stimulated activation of interleukin-6 and RANTES in human airway smooth muscle cells. J Biomed Sci (2005) 0.78
Th1 cytokine-induced syndecan-4 shedding by airway smooth muscle cells is dependent on mitogen-activated protein kinases. Am J Physiol Lung Cell Mol Physiol (2012) 0.78
Pulmonary spray dried powders of tobramycin containing sodium stearate to improve aerosolization efficiency. Pharm Res (2009) 0.78
Cyclin D1 in ASM Cells from Asthmatics Is Insensitive to Corticosteroid Inhibition. J Allergy (Cairo) (2012) 0.77
Thiazolidinediones inhibit airway smooth muscle release of the chemokine CXCL10: in vitro comparison with current asthma therapies. Respir Res (2012) 0.77
Repression of breast cancer cell growth by proteasome inhibitors in vitro: impact of mitogen-activated protein kinase phosphatase 1. Cancer Biol Ther (2015) 0.75
Acceptability of willingness to pay techniques to consumers. Health Expect (2002) 0.75
The nucleotide-binding domain and leucine-rich repeat protein-3 inflammasome is not activated in airway smooth muscle upon toll-like receptor-2 ligation. Am J Respir Cell Mol Biol (2013) 0.75
Green Fabrication of Silkworm Cocoon-like Silicon-Based Composite for High-Performance Li-Ion Batteries. ACS Nano (2017) 0.75
Numerical iterative approach for zero-order term elimination in off-axis digital holography. Opt Express (2013) 0.75
Structure-based Low-Rank Model with Graph Nuclear Norm Regularization for Noise Removal. IEEE Trans Image Process (2016) 0.75